Moderna plans booster doses to help fight virus
While some countries already have begun offering a third dose to vulnerable groups with weak immune systems, US health authorities havent called for boosters.
- Country:
- United States
Moderna officials say while its COVID-19 vaccine's protection is holding up, it's planning for booster doses to help fight the highly contagious delta variant.
With "the rising force of infection" from that variant and eventual waning immunity, a "booster will likely be necessary to keep us as safe as possible" this winter, Moderna President Dr Stephen Hoge told investors.
The shots remain 93% effective four-to-six months after the second dose, according to the latest tracking of Moderna's 30,000-person vaccine study, the company reported Thursday. But that came before the recent surge in delta-caused COVID-19 cases.
Real-world evidence from multiple countries shows protection, especially against hospitalisations and deaths, remains strong against the delta variant.
Hoge says a half-dose of the original vaccine given six-to-eight months after people's second shot may provide a sufficient boost. He cited a small study showing that triggered increases in antibody levels high enough to fight variants, including delta.
Moderna and competitor Pfizer are studying a variety of booster strategies. While some countries already have begun offering a third dose to vulnerable groups with weak immune systems, US health authorities haven't called for boosters.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- delta
- Moderna
- Pfizer
- Stephen Hoge
ALSO READ
Delta Air to resume flights to Israel starting June 7
Delta Air to resume flights to Israel starting June 7
Sixteen Nigerian soldiers killed in community clashes in Delta state
Tears of Tamil Nadu's delta farmers will bring defeat to DMK, says AIADMK chief Palaniswami.
Delta flight cut short after panel behind engine fell off during takeoff